Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,836,104
  • Shares Outstanding, K 117,708
  • Annual Sales, $ 23,870 K
  • Annual Income, $ -290,060 K
  • 60-Month Beta 1.50
  • Price/Sales 165.11
  • Price/Cash Flow N/A
  • Price/Book 9.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.44
  • Number of Estimates 5
  • High Estimate -0.42
  • Low Estimate -0.48
  • Prior Year -1.16
  • Growth Rate Est. (year over year) +62.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.70 +17.11%
on 05/13/20
35.13 -7.66%
on 05/11/20
+0.81 (+2.56%)
since 04/28/20
3-Month
20.53 +58.01%
on 03/19/20
35.13 -7.66%
on 05/11/20
+4.15 (+14.67%)
since 02/28/20
52-Week
9.51 +241.11%
on 07/22/19
35.13 -7.66%
on 05/11/20
+20.40 (+169.44%)
since 05/28/19

Most Recent Stories

More News
Momenta Pharmace Has Returned 7.6% Since SmarTrend Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on March 26th, 2020 at $28.54. In approximately 2 months, Momenta Pharmace has returned 7.64% as of today's recent price of $30.72.

MNTA : 32.27 (-0.98%)
Momenta: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Thursday reported a loss of $39.6 million in its first quarter.

MNTA : 32.27 (-0.98%)
Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results

-- Top-line interim data from nipocalimab Vivacity-MG study expected by Q3 2020 --

MNTA : 32.27 (-0.98%)
Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and Webcast

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 32.27 (-0.98%)
10.5% Return Seen to Date on SmarTrend Momenta Pharmace Call (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on March 26th, 2020 at $28.54. In approximately 4 weeks, Momenta Pharmace has returned 10.51% as of today's recent price of $31.54.

MNTA : 32.27 (-0.98%)
Momenta Pharmace Rises 4.36% on Heavy Volume: Watch For Potential Pullback

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $28.63 to a high of $34.63. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high...

MNTA : 32.27 (-0.98%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Myriad Genetics (MYGN , FLXN , MNTA , XBIT , CCXI )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

FLXN : 11.67 (+12.97%)
MNTA : 32.27 (-0.98%)
MYGN : 14.63 (+0.27%)
Momenta Provides Corporate Update Amid COVID-19 Pandemic

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today provided an update...

MNTA : 32.27 (-0.98%)
Momenta (MNTA) Down 0.3% Since Last Earnings Report: Can It Rebound?

Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MNTA : 32.27 (-0.98%)
Shares of Emergent Biosolu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (EBS , MNTA , EGRX , CVM, BIIB )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

EGRX : 52.31 (-2.06%)
EBS : 83.03 (-1.31%)
MNTA : 32.27 (-0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MNTA with:

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 35.44
1st Resistance Point 34.02
Last Price 32.27
1st Support Level 31.13
2nd Support Level 29.66

See More

52-Week High 35.13
Last Price 32.27
Fibonacci 61.8% 25.34
Fibonacci 50% 22.32
Fibonacci 38.2% 19.30
52-Week Low 9.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar